Fierce names Kevin Bennett, Ph.D., as one of its Fierce 50 Honorees of 2024
Fierce Life Sciences and Fierce Healthcare have named Kevin Bennett, Ph.D., as one of 2024’s Fierce 50 honorees. The Fierce 50 showcases 50 individuals and companies driving advancements in medicine, fostering innovation, and shaping the future of biopharma and healthcare. Bennett has received a nomination in the “Health Equity” category.